Zentalis Pharma's Q1 Cash, Cash Equivalents and Marketable Securities Position Of $489M Is Expected To Provide Cash Runway Into Mid-2026
Zentalis Pharma第一季度现金、现金等价物和有价证券头寸为4.89亿美元,预计将为2026年中期提供现金流
Zentalis Pharma's Q1 Cash, Cash Equivalents and Marketable Securities Position Of $489M Is Expected To Provide Cash Runway Into Mid-2026
Zentalis Pharma第一季度现金、现金等价物和有价证券头寸为4.89亿美元,预计将为2026年中期提供现金流
使用浏览器的分享功能,分享给你的好友吧